Healthcare entity
Mehmet Oz is most often covered alongside Donald Trump, which appears in 2 of these 4 stories. Coverage clusters in regulation, which accounts for 3 of those 4, with the remainder spread across 1 other category. Across a 53-day span, the pace is roughly 0.5 stories per week.
Last mentioned: Aug 13, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 75 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Mehmet Oz is most often covered alongside Donald Trump, which appears in 2 of these 4 stories. Coverage clusters in regulation, which accounts for 3 of those 4, with the remainder spread across 1 other category. Across a 53-day span, the pace is roughly 0.5 stories per week. Their average consequence score of 6.5 runs above the beat's 6 for that window. They are less corroborated than the beat average, carrying 3.3 original sources each against 4 for the same window. We currently track 4 Healthcare stories that mention Mehmet Oz, published between June 22, 2026 and August 13, 2026.
Computed from the 4 stories linked to this entity, with beat comparisons drawn from all 419 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Mehmet Oz. Shared-story counts are live from our verified record — not editorial picks.
Federal funding restrictions take effect
Medicaid and CHIP stop covering puberty blockers, cross-sex hormones, and surgical procedures for minors, with a six-month taper for current hormone therapy patients.
Trump announces funding cutoff on Truth Social
President Trump called the treatments 'barbaric surgeries' and said the government would not pay for harms to minors.
Pediatricians, endocrinologists, and health systems must prepare for an October 13 loss of Medicaid and CHIP reimbursement for puberty blockers, cross-sex hormones, and surgeries for minors. Current hormone therapy patients get a six-month taper, while mental health coverage remains intact.
Source: russiaherald.com · austinglobe.com
Starting October 13, federal Medicaid will cease covering hormone therapy and surgeries for transgender minors, with a six-month transition period. Healthcare providers face clinical and ethical dilemmas as patients must abruptly find alternatives or self-pay, heightening mental health risks.
Source: 600wrec.iheart.com · knrs.iheart.com
Steep premium and deductible increases have driven nearly 3 million Americans off ACA marketplace coverage, even as the Trump administration blames fraud. The erosion of affordability threatens to reverse historic gains in insurance coverage.
The WISeR pilot, using AI for prior authorization in traditional Medicare, is causing weeks-long delays for patients in Washington state, prompting Senator Maria Cantwell to say it overrides doctors and denies care. The program affects 6.4 million beneficiaries across six states.
Mehmet Oz is linked from 4 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
